Harrow, Inc. (NASDAQ:HROW – Get Free Report) was the target of a large increase in short interest in March. As of March 31st, there was short interest totalling 6,120,000 shares, an increase of 11.3% from the March 15th total of 5,500,000 shares. Based on an average daily trading volume, of 427,600 shares, the days-to-cover ratio is currently 14.3 days.
Wall Street Analyst Weigh In
HROW has been the topic of several recent research reports. Craig Hallum started coverage on Harrow in a research report on Thursday, April 11th. They issued a “buy” rating and a $24.00 price target on the stock. B. Riley dropped their price objective on Harrow from $30.00 to $26.00 and set a “buy” rating on the stock in a research note on Friday, March 22nd.
Check Out Our Latest Report on Harrow
Insider Activity at Harrow
Institutional Investors Weigh In On Harrow
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Allspring Global Investments Holdings LLC bought a new stake in Harrow during the third quarter worth about $26,000. Stonehage Fleming Financial Services Holdings Ltd bought a new position in shares of Harrow in the third quarter valued at $34,000. China Universal Asset Management Co. Ltd. increased its holdings in Harrow by 347.5% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 4,063 shares of the company’s stock worth $46,000 after buying an additional 3,155 shares during the last quarter. Tower Research Capital LLC TRC raised its position in Harrow by 122.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 8,073 shares of the company’s stock worth $90,000 after acquiring an additional 4,440 shares in the last quarter. Finally, BNP Paribas Financial Markets lifted its stake in Harrow by 12.7% in the first quarter. BNP Paribas Financial Markets now owns 16,941 shares of the company’s stock valued at $224,000 after acquiring an additional 1,912 shares during the last quarter. 72.76% of the stock is currently owned by institutional investors and hedge funds.
Harrow Stock Up 3.1 %
NASDAQ HROW traded up $0.32 on Tuesday, reaching $10.81. The company had a trading volume of 109,519 shares, compared to its average volume of 430,917. The company’s fifty day moving average is $11.45 and its 200-day moving average is $10.97. The firm has a market capitalization of $382.46 million, a price-to-earnings ratio of -14.41 and a beta of 0.58. The company has a debt-to-equity ratio of 2.60, a quick ratio of 2.61 and a current ratio of 2.83. Harrow has a 1-year low of $7.60 and a 1-year high of $28.25.
Harrow (NASDAQ:HROW – Get Free Report) last announced its earnings results on Tuesday, March 19th. The company reported ($0.27) earnings per share (EPS) for the quarter. The firm had revenue of $36.36 million during the quarter, compared to analyst estimates of $37.65 million. Harrow had a negative net margin of 18.75% and a negative return on equity of 29.48%. On average, research analysts forecast that Harrow will post -0.39 earnings per share for the current fiscal year.
Harrow Company Profile
Harrow Health, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company also holds equity interests in Surface Ophthalmics, Inc, a clinical-stage pharmaceutical company that focuses on the development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc, a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc, a commercial-stage pharmaceutical company that engages in developing and commercializing drug products.
Read More
- Five stocks we like better than Harrow
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Garmin Navigates to New Highs Driven By Wearables Trend
- Manufacturing Stocks Investing
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- The Significance of Brokerage Rankings in Stock Selection
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Harrow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Harrow and related companies with MarketBeat.com's FREE daily email newsletter.